Nastavno na inicijativu povodom obilježavanja Dana dijabetesa 2014. godine u svrhu prevencije komplikacija te u svrhu bolje kvalitete života djece i mladih oboljelih od dijabetesa tipa 1 i obitelji,
a vezano na osnivanje Povjerenstva Ministarstva zdravlja za analizu i preporuke primjene indijske konoplje/kanabinoida u medicinske svrhe u Hrvatskoj ovo je
INICIJATIVA
za provjeru mogućnosti primjene medicinske konoplje za liječenje dijabetesa tipa 1
O mogućoj primjeni u liječenju dijabetesa tipa 1 te komplikacija govore mnogi članci dostupni preko medija, a ovdje kao primjer navodimo sljedeće:
Izvor : http://www.ncbi.nlm.nih.gov/pubmed/21484568
“…On the other hand, evidence is emerging that some nonpsychotropic plant cannabinoids, such as cannabidiol, can be employed to retard β-cell damage in type 1 diabetes…”
Izvor: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/
“Cannabinoids & other inflammatory diseases
…Insulin-dependent Type 1 diabetes mellitus (T1DM) is an autoimmune disease resulting in destruction of insulin-producing pancreatic β cells, a process that is assumed to be mediated mainly by CD4 Th1 and CD8 T lymphocytes [125]. In rodents, T1D is induced by administration of multiple low doses of streptozotocin (MLDSTZ). This model is used for studying autoimmune processes associated with pancreatic β-cell pathogenesis. A study performed by Li et al. indicated that Δ9-THC could exert a transient attenuation of MLDSTZ-induced autoimmune diabetes. Δ9-THC treated (150 mg/kg) CD-1 mice exhibited reduced hyperglycemia and a significant decrease in the loss of pancreatic insulin. MLDSTZ-induced insulitis was also significantly attenuated by decreases in CD3+ inflammatory cells in the pancreatic islets and in mRNA expression for IL-12, IFN-γ and TNF-α. It was suggested that in this model, the autoimmune component was most effectively modulated by Δ9-THC treatment [126]. (…)Thus, cannabinoids can be considered useful for controlling T1D due to their anti-inflammatory properties.” Izvor
Nadamo se da ćete uvažiti potrebe djece i mladih, odnosno svih osoba oboljelih od dijabetesa tipa 1. Molimo vas da inicijativu proslijedite svim nadležnim uredima i osobama.
Dopis je poslan danas (20.2.2015.) na adresu:
Ministarstvo zdravlja
ministar Siniša Varga
Povjerenstvo za analizu i preporuke primjene indijske konoplje/kanabinoida u medicinske svrhe u Hrvatskoj
Ognjen Brborović i drugi članovi Povjerenstva